Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.6.0.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Revenues:      
Revenue from services $ 1,012,129 $ 329,739 $ 8,666
Revenue from products 83,467 80,146 76,983
Revenue from transfer of intellectual property and other 126,065 81,853 5,476
Total revenues 1,221,661 491,738 91,125
Costs and expenses:      
Cost of service revenue 564,103 193,305 9,372
Cost of product revenue 47,379 41,934 38,637
Selling, general and administrative 490,888 196,576 57,940
Research and development 111,205 99,488 83,571
In-process research and development 0 0 12,055
Contingent consideration 16,954 5,050 24,446
Amortization of intangible assets 64,407 27,977 10,919
Grant repayment 0 25,889 0
Total costs and expenses 1,294,936 590,219 236,940
Operating loss (73,275) (98,481) (145,815)
Other income and (expense), net:      
Interest income 478 255 771
Interest expense (7,430) (8,419) (12,263)
Fair value changes of derivative instruments, net 2,778 (39,083) (10,632)
Other income (expense), net 3,903 7,730 (3,088)
Other income and (expense), net (271) (39,517) (25,212)
Loss before income taxes and investment losses (73,546) (137,998) (171,027)
Income tax benefit (provision) 56,115 113,675 (24)
Net loss before investment losses (17,431) (24,323) (171,051)
Loss from investments in investees (7,652) (7,105) (3,587)
Net loss (25,083) (31,428) (174,638)
Less: Net loss attributable to noncontrolling interests 0 (1,400) (2,972)
Net loss attributable to common shareholders $ (25,083) $ (30,028) $ (171,666)
Loss per share, basic and diluted:      
Net loss per share (in dollars per share) $ (0.05) $ (0.06) $ (0.41)
Weighted average number of common shares outstanding, basic and diluted (in shares) 550,846,553 488,065,908 422,014,039